I was immeasurably relieved to see a study last week in the American Journal of Psychiatry that indicated that suicide rates dropped among depressed people soon after they started treatment with antidepressants or psychotherapy.

You might wonder why I say I was relieved instead of just pleased. Mainly because SSRI antidepressants have been taking it on the chin since 2004, especially when it comes to adolescents or children being treated with them. It was in 2004 that studies came out that indicated that younger patients on SSRI antidepressants had a higher rate of suicide. This, combined with a suit by a publicity-seeking state attorney general against GlaxoSmithKline, led the FDA to institute a “black box” warning on all SSRI antidepressants except Prozac.

Read on